In search of the "IDEAL" left main coronary stent and DAPT regimen.
作者信息
Stone Gregg W, Bohra Chandrashekar
机构信息
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
出版信息
EuroIntervention. 2022 Apr 22;17(18):1457-1459. doi: 10.4244/EIJ-E-22-00006.
Abstract
摘要
相似文献
1
In search of the "IDEAL" left main coronary stent and DAPT regimen.
EuroIntervention. 2022 Apr 22;17(18):1457-1459. doi: 10.4244/EIJ-E-22-00006.
2
Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial.
Am Heart J. 2017 May;187:104-111. doi: 10.1016/j.ahj.2017.02.015. Epub 2017 Feb 20.
3
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
EuroIntervention. 2022 Apr 22;17(18):1467-1476. doi: 10.4244/EIJ-D-21-00514.
4
Dual Antiplatelet Therapy Duration Determines Outcome After 2- But Not 1-Stent Strategy in Left Main Bifurcation Percutaneous Coronary Intervention.
JACC Cardiovasc Interv. 2018 Dec 24;11(24):2453-2463. doi: 10.1016/j.jcin.2018.09.020.
5
Overcoming challenges in refining the current generation of coronary stents.
Expert Rev Cardiovasc Ther. 2021 Nov;19(11):1013-1028. doi: 10.1080/14779072.2021.2013810.
6
Dual antiplatelet therapy after percutaneous coronary intervention for left main coronary artery disease.
Rev Esp Cardiol (Engl Ed). 2023 Apr;76(4):245-252. doi: 10.1016/j.rec.2022.07.007. Epub 2022 Jul 27.
7
Validating Utility of Dual Antiplatelet Therapy Score in a Large Pooled Cohort From 3 Japanese Percutaneous Coronary Intervention Studies.
Circulation. 2018 Feb 6;137(6):551-562. doi: 10.1161/CIRCULATIONAHA.117.028924. Epub 2017 Oct 5.
8
Clopidogrel Monotherapy More Effective Than Aspirin to Prevent Coronary Events After PCI With Drug-Eluting Stents.
Am Fam Physician. 2022 Feb 1;105(2):203-204.
9
Drug-eluting stents in elderly patients with coronary artery disease (SENIOR): a randomised single-blind trial.
Lancet. 2018 Jan 6;391(10115):41-50. doi: 10.1016/S0140-6736(17)32713-7. Epub 2017 Nov 1.
10
Dual antiplatelet therapy after coronary drug-eluting stent implantation in China: A large single center study.
Catheter Cardiovasc Interv. 2018 Feb 15;91(S1):566-572. doi: 10.1002/ccd.27500. Epub 2018 Jan 23.
引用本文的文献
1
Rehospitalization After PCI vs CABG for Left Main Disease: Refocusing Our Lens.
J Am Coll Cardiol. 2024 Mar 19;83(11):1082-1084. doi: 10.1016/j.jacc.2024.01.028.
本文引用的文献
1
Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial.
EuroIntervention. 2022 Apr 22;17(18):1467-1476. doi: 10.4244/EIJ-D-21-00514.
2
Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in left main coronary artery disease: an individual patient data meta-analysis.
Lancet. 2021 Dec 18;398(10318):2247-2257. doi: 10.1016/S0140-6736(21)02334-5. Epub 2021 Nov 15.
3
Long-term follow-up after ultrathin vs. conventional 2nd-generation drug-eluting stents: a systematic review and meta-analysis of randomized controlled trials.
Eur Heart J. 2021 Jul 15;42(27):2643-2654. doi: 10.1093/eurheartj/ehab280.
4
Intravascular Imaging and 12-Month Mortality After Unprotected Left Main Stem PCI: An Analysis From the British Cardiovascular Intervention Society Database.
JACC Cardiovasc Interv. 2020 Feb 10;13(3):346-357. doi: 10.1016/j.jcin.2019.10.007.
5
Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
J Am Coll Cardiol. 2017 Dec 26;70(25):3113-3122. doi: 10.1016/j.jacc.2017.10.036. Epub 2017 Oct 30.
6
Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.
J Am Coll Cardiol. 2017 Nov 28;70(21):2605-2617. doi: 10.1016/j.jacc.2017.09.1066. Epub 2017 Oct 30.
7
Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.
J Am Coll Cardiol. 2017 Apr 25;69(16):2011-2022. doi: 10.1016/j.jacc.2017.02.029.
8
Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
J Am Coll Cardiol. 2014 Feb 4;63(4):299-307. doi: 10.1016/j.jacc.2013.09.061. Epub 2013 Nov 6.
9
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
N Engl J Med. 2007 Mar 8;356(10):998-1008. doi: 10.1056/NEJMoa067193. Epub 2007 Feb 12.
Zotero 插件